News | Health & Safety
21 Jan 2018 18:04
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Days of Xmas
  • Sport
  • Weather
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge gets $3m extension to grant

    Pacific Edge has won a two-year extension to its research grant to fund the development of its Cxbladder products for bladder cancer detection.


    Pacific Edge has won a two-year extension to its Callaghan Innovation research grant to fund the development of its Cxbladder diagnostic suite of products for bladder cancer detection.

    The Dunedin-based firm has received up to $3 million of extra funding for research and development spread over two years, on top of an initial three-year grant of $4.5m it received in 2014, it said in a statement.

    Since the first grant was awarded, Pacific Edge has launched three new products to add to the original bladder cancer diagnostics test, with each test addressing different clinical needs.

    The shares rose 3.5 per cent to 59 cents.

    "Investment into research and development is a major focus for Pacific Edge and we are continually looking at how we can provide better and more targeted diagnostic tools for clinicians and their patients," chief executive David Darling said.

    "The Growth Grant supplements Pacific Edge's own investment into R&D and will enable us to bring new innovations through into new products and product improvements."

    The company raised $8 million in February through a share placement to institutional investors to shore up its balance sheet as it ramps up efforts to lift commercial growth.

    It started making commercial sales in 2013 and at the time was targeting $100m in gross revenue within five years.

    The recent capital raise left it with $9m of cash to fund its immediate growth needs, and when reporting its first half result in November it signalled plans to have all four Cxbladder products fully launched in the US by 2018.

    # (BusinessDesk receives funding from Callaghan Innovation to help cover the commercialisation of innovation.)


    NZN




    © 2018 NZN, NZCity


     Other Health & Safety News
     19 Jan: Blood test that can detect eight of the most common cancers could be available in next few years
     19 Jan: Most kids still drink full-fat milk: study
     18 Jan: NZ shares mixed, F&P and Air NZ drop
     18 Jan: Research aims to reduce sexual crimes
     17 Jan: NZ shares mixed: Synlait, A2, F&P gain
     17 Jan: Former Home and Away actress Jessica Falkholt dies in hospital
     17 Jan: Gestational diabetes link to heart disease
     Top Stories

    RUGBY RUGBY
    Liam Messam signs for Toulon More...


    BUSINESS BUSINESS
    Auckland commuters face motorway closure More...



     Today's News

    Hockey:
    Belgium win Four Nations, Black Sticks 3rd 16:46

    Cricket:
    Sodhi keen to impress in Black Caps T20s 16:46

    Politics:
    Prime Minister discusses 100-day plan 16:16

    General:
    The Korean War, families divided and an Australian Olympian... one hell of a bedtime story 16:06

    Politics:
    Govt tree target a 'mirage': opposition 15:06

    Politics:
    Donald Trump's top 10 moments from year one in the White House 14:46

    Basketball:
    Adams stars in OKC's NBA romp over Cavs 14:36

    Basketball:
    Henare down on himself after Breakers loss 13:56

    Golf:
    Fox, Lee slip back in men's golf events 13:06

    Law and Order:
    Man hurt in Christchurch assault: police 12:56


     News Search






    Power Search


    © 2018 New Zealand City Ltd